 Darren Gregory
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stevens-Johnson Syndrome | 10 | 2018 | 37 | 1.980 |
Why?
| | Dry Eye Syndromes | 11 | 2025 | 56 | 1.890 |
Why?
| | Amnion | 7 | 2017 | 31 | 1.390 |
Why?
| | Conjunctival Diseases | 7 | 2017 | 23 | 1.380 |
Why?
| | Phacoemulsification | 2 | 2014 | 123 | 0.660 |
Why?
| | Corneal Diseases | 4 | 2018 | 46 | 0.660 |
Why?
| | Glucocorticoids | 5 | 2024 | 532 | 0.610 |
Why?
| | Education, Medical, Graduate | 2 | 2014 | 562 | 0.510 |
Why?
| | Ophthalmology | 3 | 2015 | 120 | 0.470 |
Why?
| | Eyelid Diseases | 2 | 2016 | 26 | 0.440 |
Why?
| | Internship and Residency | 2 | 2014 | 1269 | 0.350 |
Why?
| | Teaching | 1 | 2014 | 237 | 0.340 |
Why?
| | Learning Curve | 1 | 2011 | 71 | 0.320 |
Why?
| | Acute Disease | 5 | 2016 | 1036 | 0.310 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1925 | 0.250 |
Why?
| | Clinical Competence | 2 | 2014 | 1247 | 0.240 |
Why?
| | Visual Acuity | 4 | 2016 | 490 | 0.220 |
Why?
| | Pemphigoid, Benign Mucous Membrane | 1 | 2024 | 6 | 0.210 |
Why?
| | Blindness, Cortical | 1 | 2003 | 6 | 0.200 |
Why?
| | Cataract Extraction | 1 | 2025 | 120 | 0.190 |
Why?
| | Masks | 1 | 2023 | 70 | 0.190 |
Why?
| | Ophthalmic Solutions | 2 | 2024 | 82 | 0.180 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 156 | 0.180 |
Why?
| | Lens Implantation, Intraocular | 2 | 2014 | 80 | 0.180 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 206 | 0.170 |
Why?
| | Tobramycin | 2 | 2022 | 63 | 0.160 |
Why?
| | Epithelium, Corneal | 2 | 2018 | 41 | 0.160 |
Why?
| | Tears | 3 | 2025 | 27 | 0.160 |
Why?
| | Cyclosporine | 2 | 2022 | 256 | 0.150 |
Why?
| | Air Pollution | 1 | 2023 | 315 | 0.150 |
Why?
| | Cryopreservation | 2 | 2011 | 113 | 0.140 |
Why?
| | Serum | 1 | 2018 | 58 | 0.130 |
Why?
| | Humans | 27 | 2025 | 145783 | 0.130 |
Why?
| | Fluorophotometry | 1 | 2016 | 3 | 0.120 |
Why?
| | Explosions | 1 | 2016 | 14 | 0.120 |
Why?
| | Cicatrix | 1 | 2017 | 69 | 0.120 |
Why?
| | Eye Burns | 1 | 2016 | 14 | 0.120 |
Why?
| | Sclera | 1 | 2016 | 36 | 0.120 |
Why?
| | Conjunctivitis | 2 | 2024 | 30 | 0.120 |
Why?
| | Fluoroquinolones | 1 | 2016 | 44 | 0.120 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1271 | 0.120 |
Why?
| | Lacerations | 1 | 2016 | 40 | 0.120 |
Why?
| | Blast Injuries | 1 | 2016 | 62 | 0.120 |
Why?
| | Corneal Injuries | 1 | 2016 | 42 | 0.110 |
Why?
| | Female | 16 | 2024 | 79045 | 0.110 |
Why?
| | Hutchinson's Melanotic Freckle | 1 | 2015 | 3 | 0.110 |
Why?
| | Eyelid Neoplasms | 1 | 2015 | 10 | 0.110 |
Why?
| | Melanosis | 1 | 2015 | 16 | 0.110 |
Why?
| | Cryotherapy | 1 | 2015 | 21 | 0.110 |
Why?
| | Conjunctiva | 2 | 2023 | 52 | 0.110 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2016 | 110 | 0.110 |
Why?
| | Tissue Preservation | 2 | 2011 | 11 | 0.100 |
Why?
| | Guidelines as Topic | 1 | 2016 | 268 | 0.100 |
Why?
| | Lubricant Eye Drops | 2 | 2024 | 9 | 0.100 |
Why?
| | Dexamethasone | 1 | 2016 | 365 | 0.100 |
Why?
| | Meibomian Glands | 2 | 2024 | 17 | 0.100 |
Why?
| | Operative Time | 1 | 2014 | 181 | 0.100 |
Why?
| | Hospital Costs | 1 | 2014 | 125 | 0.090 |
Why?
| | Operating Rooms | 1 | 2014 | 144 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2025 | 2977 | 0.090 |
Why?
| | Orbital Diseases | 1 | 2012 | 37 | 0.090 |
Why?
| | Cataract | 2 | 2022 | 238 | 0.090 |
Why?
| | Microsurgery | 1 | 2012 | 76 | 0.090 |
Why?
| | Disease Management | 1 | 2015 | 653 | 0.080 |
Why?
| | Prevalence | 3 | 2024 | 2875 | 0.080 |
Why?
| | Prospective Studies | 2 | 2016 | 8078 | 0.080 |
Why?
| | Male | 12 | 2024 | 73010 | 0.080 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 90 | 0.080 |
Why?
| | Brain | 1 | 2003 | 2969 | 0.080 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 121 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2933 | 0.080 |
Why?
| | Child, Preschool | 5 | 2022 | 11868 | 0.070 |
Why?
| | Physician's Role | 1 | 2010 | 225 | 0.070 |
Why?
| | Adipose Tissue | 1 | 2012 | 645 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1582 | 0.060 |
Why?
| | Aged | 4 | 2024 | 26217 | 0.060 |
Why?
| | Chronic Disease | 1 | 2013 | 1812 | 0.060 |
Why?
| | Scleritis | 1 | 2007 | 28 | 0.060 |
Why?
| | Retinitis Pigmentosa | 1 | 2006 | 20 | 0.060 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2006 | 27 | 0.060 |
Why?
| | Adult | 6 | 2024 | 40881 | 0.060 |
Why?
| | Myopia | 1 | 2006 | 59 | 0.060 |
Why?
| | Surgical Flaps | 1 | 2007 | 142 | 0.060 |
Why?
| | Quality of Life | 3 | 2025 | 3211 | 0.060 |
Why?
| | Incidence | 2 | 2022 | 2934 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1969 | 0.050 |
Why?
| | Child | 5 | 2022 | 22740 | 0.050 |
Why?
| | Brazil | 1 | 2024 | 179 | 0.050 |
Why?
| | Adolescent | 4 | 2022 | 22577 | 0.050 |
Why?
| | Loteprednol Etabonate | 1 | 2022 | 5 | 0.050 |
Why?
| | Time Factors | 1 | 2014 | 7134 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2024 | 5428 | 0.050 |
Why?
| | Cornea | 1 | 2023 | 154 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2024 | 260 | 0.040 |
Why?
| | Retrospective Studies | 5 | 2024 | 17330 | 0.040 |
Why?
| | Middle Aged | 3 | 2024 | 36309 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 173 | 0.040 |
Why?
| | Life Style | 1 | 2023 | 486 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 11794 | 0.040 |
Why?
| | Particulate Matter | 1 | 2023 | 326 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 484 | 0.040 |
Why?
| | Suture Techniques | 2 | 2012 | 137 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 733 | 0.030 |
Why?
| | Cranial Nerve Diseases | 1 | 2018 | 44 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2024 | 8347 | 0.030 |
Why?
| | Facial Injuries | 1 | 2016 | 25 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1752 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1139 | 0.030 |
Why?
| | Epidermis | 1 | 2016 | 156 | 0.030 |
Why?
| | Aminoquinolines | 1 | 2015 | 18 | 0.030 |
Why?
| | Necrosis | 1 | 2016 | 244 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2022 | 3634 | 0.030 |
Why?
| | Eye Diseases | 1 | 2016 | 97 | 0.030 |
Why?
| | Administration, Topical | 1 | 2015 | 155 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 14254 | 0.030 |
Why?
| | Interferon-alpha | 1 | 2015 | 193 | 0.020 |
Why?
| | Infant | 2 | 2018 | 10091 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2770 | 0.020 |
Why?
| | Prolapse | 1 | 2012 | 6 | 0.020 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 20 | 0.020 |
Why?
| | Tissue Adhesives | 1 | 2012 | 21 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 766 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1368 | 0.020 |
Why?
| | Biological Dressings | 1 | 2010 | 2 | 0.020 |
Why?
| | Skin | 1 | 2016 | 754 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 6085 | 0.020 |
Why?
| | Pregnancy | 1 | 2003 | 7216 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5925 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2010 | 189 | 0.020 |
Why?
| | Wound Healing | 1 | 2009 | 355 | 0.020 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2006 | 32 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2006 | 31 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 2006 | 36 | 0.010 |
Why?
| | Electroretinography | 1 | 2006 | 51 | 0.010 |
Why?
| | United States | 1 | 2024 | 16126 | 0.010 |
Why?
| | Visual Fields | 1 | 2006 | 116 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2006 | 189 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 2007 | 1180 | 0.010 |
Why?
|
|
Gregory's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|